Abstract
Gaucher disease is characterized as an autosomal recessive disorder caused by mutations in the enzyme ²-glucocerebrosidase (GBA) gene. This disease has no cure, only treatment. One of the current treatment consists of replacement therapy via intravenous infusions of GBA placenta-derived (pGBA) or recombinant GBA (rGBa). Despite the advantages of rGBA compared to pGBA, such as reducing the…